Lamellasomes, multilamellar liposomes for use in the
treatment of oral and respiratory diseases

Investors

Lamellar Biomedical Ltd is currently funded by private investors including Barwell plc, TRI Capital Ltd and the Scottish Co-Investment Fund. 

The Company is aware of the variety of funding options available at this time and actively seeks investors to fund the development of the business.

To discuss potential investment opportunities in the Company please contact us on +44 (0) 1698 748832 or at info@lamellar.com